Skip to main content

Advertisement

Table 2 Notable AMR STs by location

From: Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia

LocationTotal ESBL (%)Total CP (%)Notable clone/sNN ESBL (% of ESBL/site)ESBL genes (N)N CP (% of CP/site)CP genes (N)
Hong Kong5 (19%)0
Vietnam20 (25%)4 (5%)* ST1574 (20%)CTX-M-15 (3)
CTX-M-14 (2)
2 (50%)NDM-1 (1)
Thailand2 (50%)0
Laos32 (53%)1 (2%)* ST151414 (44%)CTX-M-15 (14)0
ST76-1LV44 (13%)CTX-M-15 (4)0
Cambodia27 (64%)1 (2%)ST2055 (19%)CTX-M-27 (3)
CTX-M-14 (2)
CTX-M-15 (1)
0
* ST1533 (11%)CTX-M-15 (3)
CTX-M-27 (1)
0
ST3633 (11%)CTX-M-15 (2)0
* ST1588 (33%)CTX-M-15 (8)6 (67%)NDM-1 (5)
Nepal24 (75%)9 (28%)ST455 (21%)CTX-M-15 (5)0
ST1133 (13%)SFO-1 (3)3 (33%)OXA-232 (3)
India52 (61%)42 (49%)ST2311713 (25%)CTX-M-15 (13)13 (31%)OXA-232 (13)
ST14167 (13%)CTX-M-15 (7)11 (26%)OXA-232 (10)
* ST1543 (6%)CTX-M-15 (3)0
ST1633 (6%)CTX-M-15 (3)2 (5%)NDM-1 (1)
ST2933 (6%)CTX-M-15 (3)0
ST39531 (25%)CTX-M-15 (1)3 (7%)OXA-232 (3)
  1. Total ESBL and Total CP: total number of genomes carrying ESBL and carbapenemase genes per site, respectively
  2. Notable clones: clones with ≥ 3 ESBL and/or carbapenemase gene-positive genomes at any single site. *ST15 is the only clone meeting these criteria at > 1 site
  3. N: total number of genomes of each notable clone at each site (includes all genomes assigned to the ST regardless of predicted AMR)
  4. N ESBL: number of genomes of each notable clone with at least one ESBL and no carbapenemase genes per site
  5. ESBL genes: details of the ESBL genes detected in each notable clone at each site
  6. N CP: number of genomes of each notable clone with at least one carbapenemase gene per site
  7. CP genes: details of the carbapenemase genes detected in each notable clone at each site